Tissue expression
Cell line expression
Protein structure

ATXN1

Ataxin 1
ATX1, D6S504E, SCA1 
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames. [provided by RefSeq, Nov 2017]
More gene data

All Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
859 antibodies from 43 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
283 antibodies
OriGene
13 antibodies
GeneTex
10 antibodies
Novus Biologicals
40 antibodies
Acris Antibodies GmbH
8 antibodies
Invitrogen Antibodies
30 antibodies
Boster Biological Technology
5 antibodies
Abnova Corporation
4 antibodies
St John's Laboratory
6 antibodies
Biorbyt
58 antibodies
Cusabio Biotech Co., Ltd
6 antibodies
Affinity Biosciences
3 antibodies
Antibodies Incorporated / NeuroMab
6 antibodies
Aviva Systems Biology
4 antibodies
NovoPro Bioscience Inc.
3 antibodies
Abgent
5 antibodies
NSJ Bioreagents
2 antibodies
Bioworld Technology, Inc
1 antibody
QED Bioscience
2 antibodies
Abbkine Scientific Co.Ltd.
2 antibodies
Bethyl Laboratories
2 antibodies
UC Davis/NIH NeuroMab Facility
6 antibodies
Abbexa
32 antibodies
Creative Diagnostics
4 antibodies
Rockland Immunochemicals, Inc.
33 antibodies
Atlas Antibodies
2 antibodies
MyBioSource
15 antibodies
Creative Biolabs
19 antibodies
Leading Biology
5 antibodies
ProSci
4 antibodies
Signalway Antibody LLC
1 antibody
Absolute Antibody
6 antibodies
United States Biological
64 antibodies
Everest Biotech
2 antibodies
RayBiotech, Inc.
2 antibodies
Abiocode, Inc.
1 antibody
Cell Signaling Technology, Inc
1 antibody
Proteintech Group
1 antibody
MilliporeSigma / Merck KGaA
3 antibodies
Abbiotec
1 antibody
EMD Millipore
1 antibody